英科醫療(300677.SZ)與懷寧縣人民政府簽訂投資年產160億隻(1600萬箱)高端醫用手套項目和懷寧經開區熱電聯產項目協議書
格隆匯6月3日丨英科醫療(300677.SZ)公佈,為滿足未來戰略發展需要,公司(“乙方”)與懷寧縣人民政府(“甲方”)本着平等協商、互惠互利的原則,於2020年6月3日共同簽訂了兩份《投資協議書》:
(1)“年產160億隻(1600萬箱)高端醫用手套項目”投資協議,約定公司在懷寧經開區投資建設年產160億隻(1600萬箱)高端醫用手套項目,項目計劃總投資為15億元人民幣,其中固定資產投資10億元。
(2)“懷寧經開區熱電聯產項目”投資協議,約定公司在懷寧經開區投資建設懷寧經開區熱電聯產項目,項目計劃總投資為5億元人民幣,其中固定資產投資不低於2.75億元,註冊資本金不少於1億元。
因為此次新型冠狀病毒的影響,公司判斷未來人們的醫療防護意識會日益增強,未來醫療防護手套市場空間廣闊。此外,熱電聯產項目不僅可以提高能源的利用效率,還可以減少碳化物和有害氣體的排放,具有良好的經濟效益和社會效益。此次投資協議的簽訂旨在進行高端醫用手套項目建設,並充分利用能源,有利於公司的長期和持續發展,有利於進一步提升公司業績,鞏固公司在行業內的地位,會產生良好的經濟效益和社會效益,符合公司戰略發展方向。該項目資金來源為公司自有資金或自籌資金,不會對公司的生產經營產生不利影響,不存在損害公司及全體股東利益的情形此次投資不會損害公司及股東的利益,並預計不會對公司未來的財務狀況和經營成果產生重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.